Literature DB >> 12770672

Prednisone therapy in pediatric epilepsy.

D Barry Sinclair1.   

Abstract

Steroids are often an effective treatment for the West's syndrome. There have been few reports of steroid use in children with epilepsy outside the first year of life. I report my experience with prednisone for the treatment of older children with intractable epilepsy. Twenty-eight children (17 boys, 11 girls) aged 18 months to 10 years with intractable epilepsy were studied. Prednisone 1 mg/kg/day for 12 weeks (6 weeks daily and 6 weeks alternate therapy) was prescribed in addition to their regular antiepileptic medications. The parents kept seizure diaries, and the patients were regularly assessed for seizure frequency and side effects. The follow-up period was for 1 to 5 years. Thirteen patients (46%) became seizure free on prednisone and another 18 (40%) had a significant decrease in seizure frequency. Five patients (19%) had no change in seizure frequency. The best outcomes were seen in the absence group in which six out of seven patients became seizure free and in the Lennox-Gastaut syndrome group in which seven out of 10 became seizure free. Side effects were uncommon and included weight gain in five patients and aggression in four patients. Prednisone therapy is a safe and effective adjunctive treatment for epilepsy. It should be considered as an alternative treatment for older children with intractable generalized epilepsy who have failed conventional antiepileptic therapy.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12770672     DOI: 10.1016/s0887-8994(02)00513-1

Source DB:  PubMed          Journal:  Pediatr Neurol        ISSN: 0887-8994            Impact factor:   3.372


  12 in total

Review 1.  The role of inflammation in epilepsy.

Authors:  Annamaria Vezzani; Jacqueline French; Tamas Bartfai; Tallie Z Baram
Journal:  Nat Rev Neurol       Date:  2010-12-07       Impact factor: 42.937

2.  Intravenous methylprednisolone pulse therapy for children with epileptic encephalopathy.

Authors:  Maria Carmela Pera; Giovanna Randazzo; Silvia Masnada; Serena Donetti Dontin; Valentina De Giorgis; Umberto Balottin; Pierangelo Veggiotti
Journal:  Funct Neurol       Date:  2015 Jul-Sep

Review 3.  Medical management of Lennox-Gastaut syndrome.

Authors:  Aspasia Michoulas; Kevin Farrell
Journal:  CNS Drugs       Date:  2010-05       Impact factor: 5.749

Review 4.  Corticosteroids in the management of the paediatric epilepsies.

Authors:  R Gupta; R Appleton
Journal:  Arch Dis Child       Date:  2005-04       Impact factor: 3.791

Review 5.  Corticosteroids including ACTH for childhood epilepsy other than epileptic spasms.

Authors:  Vishal Mehta; Colin D Ferrie; J Helen Cross; Gayatri Vadlamani
Journal:  Cochrane Database Syst Rev       Date:  2015-06-18

Review 6.  Immunomodulatory therapies in neurologic critical care.

Authors:  Logan M McDaneld; Jeremy D Fields; Dennis N Bourdette; Anish Bhardwaj
Journal:  Neurocrit Care       Date:  2009-09-23       Impact factor: 3.210

7.  Utility of an immunotherapy trial in evaluating patients with presumed autoimmune epilepsy.

Authors:  M Toledano; J W Britton; A McKeon; C Shin; V A Lennon; A M L Quek; E So; G A Worrell; G D Cascino; C J Klein; T D Lagerlund; E C Wirrell; K C Nickels; S J Pittock
Journal:  Neurology       Date:  2014-04-04       Impact factor: 9.910

8.  Efficacy of anti-inflammatory therapy in a model of acute seizures and in a population of pediatric drug resistant epileptics.

Authors:  Nicola Marchi; Tiziana Granata; Elena Freri; Emilio Ciusani; Francesca Ragona; Vikram Puvenna; Quingshan Teng; Andreas Alexopolous; Damir Janigro
Journal:  PLoS One       Date:  2011-03-28       Impact factor: 3.240

Review 9.  Role of brain inflammation in epileptogenesis.

Authors:  Jieun Choi; Sookyong Koh
Journal:  Yonsei Med J       Date:  2008-02-29       Impact factor: 2.759

10.  Treatment of Lennox-Gastaut syndrome: overview and recent findings.

Authors:  Kenou van Rijckevorsel
Journal:  Neuropsychiatr Dis Treat       Date:  2008-12       Impact factor: 2.570

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.